6:30 AM ET
8-K
Clinical Trial Data
Alzamend Neuro Clinical Trial Data
Alzamend Neuro presented Phase 1/2A clinical trial data for AL001, a novel organic lithium salt, at the ISMRT Conference. The study utilized 7T MRI imaging to evaluate brain pharmacokinetics, demonstrating that AL001 is designed for improved brain delivery with lower systemic exposure compared to standard inorganic lithium salts.
- Counterparty
- Massachusetts General Hospital